Ameen v. Merck and Co Inc

226 F. App'x 363
CourtCourt of Appeals for the Fifth Circuit
DecidedMarch 29, 2007
Docket05-20068
StatusUnpublished
Cited by22 cases

This text of 226 F. App'x 363 (Ameen v. Merck and Co Inc) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ameen v. Merck and Co Inc, 226 F. App'x 363 (5th Cir. 2007).

Opinion

*366 PER CURIAM: *

Plaintiff-Appellant Tami Ameen (“Ameen” or “Appellant”), a former employee of Defendant-Appellee Merck & Co., Inc. (“Merck”), brought an action in Texas state court against Defendants-Appellees Merck, Deborah K. Winn, Robert F. Young, Alex N. Petrovich, and Bobby Griffin, (collectively, “Appellees”) in which she alleged ten causes of action under Texas law resulting from the termination of her employment at Merck. Appellees removed the case pursuant to 28 U.S.C. §§ 1332 and 1441, contending that the individual defendants had been improperly joined to defeat diversity jurisdiction. Ameen filed a motion to remand, which the district court denied, also dismissing all of Ameen’s state law claims against the individual defendants. The district court later granted Merck’s summary judgment motion to dismiss Ameen’s retaliation claim, her sole remaining cause of action. Ameen appeals both orders. We affirm.

I. Facts and Proceedings

Merck, one of the world’s largest pharmaceutical companies, uses sales representatives (“reps”) to sell its products to physicians and hospitals. As part of their responsibilities, Merck’s reps conduct health education liaison (“HEL”) programs, which usually include social activities for doctors or other health care providers. Merck maintains detailed policies and regulations governing the administration of its HEL programs, including limits on the dollar amount that may be spent per physician. One of Merck’s policies specifies that “[t]he failure of any employee to adhere strictly to both the letter and spirit of these general principles will result in appropriate action, up to and including dismissal from employment.”

Ameen, a resident of Texas, was employed by Merck for almost fourteen years. At the time of her termination, she was an executive senior representative, the highest sales position within the company. Defendant Deborah K. Winn, Ameen’s immediate supervisor, was responsible for screening potential candidates for the rep positions. She set up a team to screen applicants and asked Ameen to chair the team. Ameen has alleged that, as a member of the screening team, she observed Winn engage in discriminatory employment practices. On one occasion, for example, Winn indicated she did not want to hire an applicant because he “spoke too black”; on another, she referred to an applicant as an “old man” and indicated that he was too old to work at Merck. These practices ultimately led to the filing of charges by the rejected applicants with the Equal Employment Opportunity Commission (the “EEOC”), which investigated and substantiated the claims.

Ameen asserts that she reported discriminatory hiring practices to Defendant Alex N. Petrovich, Winn’s supervisor, in August or September 2000; Petrovich denies that Ameen informed him of these practices. In February 2001, Petrovich awarded Ameen a discretionary $3,000 bonus. In April 2001, Petrovich approved Ameen’s overall rating of “exceeds expectations” in her performance review. Petrovich also granted Ameen a 2-month sabbatical so that she could spend time with her family in the summer of 2001.

At the end of May 2001, Petrovich conducted an exit interview with a departing sales representative, who informed him that Merck’s reps had been falsifying re *367 ports for HEL programs. After Petrovich asked Winn to investigate, she determined that Ameen had falsified HEL reports, enabling her to make inappropriate payments to doctors. Petrovich then conducted his own investigation. Early in August 2001, Petrovich interviewed Ameen, and she acknowledged that she repeatedly violated Merck policy by submitting false expense information to obtain funds that she in turn gave to doctors. Petrovich decided that day to terminate Ameen, stating his reason for the dismissal as Ameen’s falsifications of HEL program expense reports in violation of Merck policy.

More than a year later, in November 2002, Ameen filed this action in state court against Appellees seeking damages for specified state law causes of action. The individual defendants are, like Ameen, residents of Texas. In her complaint, Ameen alleged retaliation, intentional infliction of emotional distress, tortious interference with her at-will employment contract, negligence, negligent misrepresentation, vicarious liability, defamation, civil conspiracy, promissory estoppel, and false imprisonment under Texas law. Appellees removed the case to federal court based on diversity jurisdiction, contending that the in-state defendants had been improperly joined. When Ameen filed a motion to remand the case to state court, the district court denied her motion without explanation.

After Ameen’s motion to remand was denied, Merck filed a motion for summary judgment. In granting Merck’s motion, the district court held that, with respect to the surviving retaliation claim, Ameen had not demonstrated a causal connection between any protected activity and her termination. The court further held that, even if she had been able to make a prima facie case of retaliation for her having engaged in a protected activity, Ameen could not defeat Merck’s legitimate nondiscriminatory reason for termination, as she had failed to demonstrate that “but for” retaliation she would not have been terminated. Ameen timely filed a notice of appeal.

II. ANALYSIS

A. Subject Matter Jurisdiction

1. Standard of Review

All questions of subject matter jurisdiction, including the denial of a motion for remand to state court and a determination that a party is improperly joined, are questions of law reviewed de novo. 1 We review a district court’s decision to pierce the pleadings and its procedure for determining improper joinder only for abuse of discretion. 2

2. Removal

Under 28 U.S.C. § 1441(a), a defendant may remove from state court to federal court any civil action over which the federal courts have original jurisdiction. When jurisdiction is based on diversity, however, a defendant may remove “only if none of the parties in interest properly joined and served as defendants is a citizen of the State in which such action is brought.” 3 Even though Ameen and the individual defendants are citizens of Texas, where this action was brought, Appellees contend that removal was nevertheless proper be *368 cause, they insist, the individual defendants were improperly joined.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
226 F. App'x 363, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ameen-v-merck-and-co-inc-ca5-2007.